Psyence Biomed Australian Subsidiary, Psyence Australia Partners With Fluence And INGENū CRO To Train Research Therapists For Phase IIb Psilocybin Trial
Psyence Biomed澳大利亞子公司Psyence Australia與Fluence和IngenuCRO合作,爲IIb期迷幻藥試驗培訓研究治療師
Psyence Biomed Australian Subsidiary, Psyence Australia Partners With Fluence And INGENū CRO To Train Research Therapists For Phase IIb Psilocybin Trial
Psyence Biomed澳大利亞子公司Psyence Australia與Fluence和IngenuCRO合作,爲IIb期迷幻藥試驗培訓研究治療師
使用瀏覽器的分享功能,分享給你的好友吧